Gabapentin for alcohol use disorder in patients with withdrawal symptoms

Participants were randomised to gabapentin ≤1,200mg/d orally or placebo and nine 20-minute medical management visits.
Participants were randomised to gabapentin ≤1,200mg/d orally or placebo and nine 20-minute medical management visits.